ALT5 Sigma (ALTS) Stock Price, News & Analysis

Company Overview

ALT5 Sigma Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. It operates under the Biotechnology and Recycling segments. The Biotechnology segment focuses on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. The Recycling segment is involved in a turnkey appliance recycling program. The company was founded by Edward R. Cameron in 1976 and is headquartered in Las Vegas, NV.

Key Stats

• Today's Range: $7.03 to $7.58
• 50-Day Range: $5.96 to $10.26
• 52-Week Range: $1.55 to $10.95
• Volume: 16.35 million shs
• Average Volume: 5.70 million shs
• Market Capitalization: $155.81 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ALT5 Sigma Stock Analysis - MarketRank™

ALT5 Sigma scored higher than 13% of companies evaluated by MarketBeat, and ranked 916th out of 942 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for ALT5 Sigma.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

ALT5 Sigma has a P/B Ratio of 13.11. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

5.58% of the float of ALT5 Sigma has been sold short.

Short Interest Ratio / Days to Cover

ALT5 Sigma has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in ALT5 Sigma has recently decreased by 15.63%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

ALT5 Sigma does not currently pay a dividend.

Dividend Growth

ALT5 Sigma does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

5.58% of the float of ALT5 Sigma has been sold short.

Short Interest Ratio / Days to Cover

ALT5 Sigma has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in ALT5 Sigma has recently decreased by 15.63%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 3.2 / 5
• News Sentiment: 0.76

News Sentiment

ALT5 Sigma has a news sentiment score of 0.76. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Finance companies.

News Coverage This Week

MarketBeat has tracked 17 news articles for ALT5 Sigma this week, compared to 0 articles on an average week.

Search Interest

12 people have searched for ALTS on MarketBeat in the last 30 days. This is an increase of 1,100% compared to the previous 30 days.

MarketBeat Follows

4 people have added ALT5 Sigma to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, ALT5 Sigma insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 4.90% of the stock of ALT5 Sigma is held by insiders.

Percentage Held by Institutions

Only 6.27% of the stock of ALT5 Sigma is held by institutions.

ALTS Stock Analysis - Frequently Asked Questions

How have ALTS shares performed this year?

ALT5 Sigma's stock was trading at $4.65 at the beginning of 2025. Since then, ALTS stock has increased by 55.1% and is now trading at $7.21.

Who are ALT5 Sigma's major shareholders?

Top institutional investors of ALT5 Sigma include Geode Capital Management LLC (0.97%), Jane Street Group LLC (0.24%), Evernest Financial Advisors LLC (0.07%) and Scotia Capital Inc. (0.05%). Insiders that own company stock include Peter Tassiopoulos and Virland A Johnson.
View institutional ownership trends.

How do I buy shares of ALT5 Sigma?

Shares of ALTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of ALT5 Sigma own?

Based on aggregate information from My MarketBeat watchlists, some other companies that ALT5 Sigma investors own include JIADE (JDZG), Hyzon Motors (HYZN), New Horizon Aircraft (HOVR), Hour Loop (HOUR), Gossamer Bio (GOSS), Genius Group (GNS) and Ford Motor (F).

Company Calendar

• Today: 8/14/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Finance
• Industry: FIN - MISC SVCS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:ALTS
• Previous Symbol: NASDAQ:ALTS
• CIK: 862861
• Web: N/A
• Phone: (702) 997-5968
• Fax: 952-930-1800
• Employees: 170
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$6.24 million
• Net Margins: -38.58%
• Pretax Margin: -53.44%
• Return on Equity: -113.79%
• Return on Assets: -8.96%

Debt

• Debt-to-Equity Ratio: 1.26
• Current Ratio: 0.83
• Quick Ratio: 0.83

Sales & Book Value

• Annual Sales: $12.53 million
• Price / Sales: 12.43
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.49 per share
• Price / Book: 14.71

Miscellaneous

• Outstanding Shares: 21,610,000
• Free Float: 19,156,000
• Market Cap: $155.81 million
• Optionable: N/A
• Beta: 2.17